Information-guided surgical management of gliomas using low-field-strength intraoperative MRI.

BACKGROUND Contemporary technological developments revolutionized management of brain tumors. The experience with information-guided surgery of gliomas, based on the integration of the various intraoperative anatomical, functional, and histological data, is reported. METHODS From 2000 to 2009, 574 surgeries for intracranial gliomas were performed in our clinic with the use of intraoperative MRI (ioMRI) with magnetic field strength of 0.3T, updated neuronavigation, neurochemical navigation with 5-aminolevulinic acid, serial intraoperative histopathological investigations of the resected tissue, and comprehensive neurophysiological monitoring. Nearly half of patients (263 cases; 45.8%) were followed more than 2 years after surgery. FINDINGS Maximal possible tumor resection, defined as radiologically complete tumor removal or subtotal removal leaving the residual neoplasm within the vital functionally-important brain areas, was attained in 569 cases (99.1%). The median resection rate constituted 95%, 95%, and 98%, for WHO grade II, III, and IV gliomas, respectively. Actuarial 5-year survival was significantly worse in WHO grade IV gliomas (19%), but did not differ significantly between WHO grade III and II tumors (69% vs. 87%). CONCLUSIONS Information-guided management of gliomas using low-field-strength ioMRI provides a good opportunity for maximal possible tumor resection, and may result in survival advantage, particularly in patients with WHO grade III neoplasms.

[1]  Hiroshi Iseki,et al.  Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma. , 2008, Japanese journal of clinical oncology.

[2]  A. Dinçer,et al.  First intraoperative, shared-resource, ultrahigh-field 3-Tesla magnetic resonance imaging system and its application in low-grade glioma resection. , 2010, Journal of neurosurgery.

[3]  Denis Lacombe,et al.  Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Veit Rohde,et al.  EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME: IDENTIFICATION OF AND ADJUSTMENT FOR BIAS , 2008, Neurosurgery.

[5]  H. Berkenstadt,et al.  Novel, Compact, Intraoperative Magnetic Resonance Imaging-guided System for Conventional Neurosurgical Operating Rooms , 2001, Neurosurgery.

[6]  Volker Seifert,et al.  USEFULNESS OF INTRAOPERATIVE ULTRA LOW‐FIELD MAGNETIC RESONANCE IMAGING IN GLIOMA SURGERY , 2008, Neurosurgery.

[7]  Christopher Nimsky,et al.  Intraoperative high-field-strength MR imaging: implementation and experience in 200 patients. , 2004, Radiology.

[8]  J G Ojemann,et al.  Preserved function in brain invaded by tumor. , 1996, Neurosurgery.

[9]  R. Nakamura,et al.  Intraoperative diffusion-weighted imaging for visualization of the pyramidal tracts. Part II: clinical study of usefulness and efficacy. , 2008, Minimally invasive neurosurgery : MIN.

[10]  H Iseki,et al.  Usefulness of intraoperative magnetic resonance imaging for glioma surgery. , 2006, Acta neurochirurgica. Supplement.

[11]  Akira Uchino,et al.  Histologically classified venous angiomas of the brain: a controversy. , 2003, Neurologia medico-chirurgica.

[12]  H Iseki,et al.  Advanced Computer-aided Intraoperative Technologies for Information-guided Surgical Management of Gliomas: Tokyo Women's Medical University Experience , 2008, Minimally invasive neurosurgery : MIN.